Responsiveness to Change and Minimally Important Differences of the Patient-Reported Outcomes Measurement Information System Gastrointestinal Symptoms Scales
Year: 2017
Type: article
Study design: Observational Study
Source: Digestive Diseases and Sciences
Language: English
Field: Decision Sciences
Domain: Social Sciences
Open Access status: green
Funders: Amgen, Pfizer, Sanofi, Gilead Sciences, Celgene, Ironwood Pharmaceuticals, Incorporated, Luitpold Pharmaceuticals, Shire, National Institutes of Health, Genentech, Allergan, National Institute on Aging, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Awards: G1199450590, University of Michigan Center for Gastrointestinal Research, G1811705053, G2319063652, The National Person-Centered Assessment Resource (PCAR), G4250655629, Academic Training in Rheumatology, Center for Neurovisceral Sciences & Women's Health, Outcomes Research in Rheumatic Diseases, Development and Initial Validation of PROMIS GI Distress Scale, Training for Research in Gastroenterology, G75062253, G768952255, NIH PROMIS Statistical Coordinating Center(RMI), UCLA Older Americans Independence Center, G837983217, G9000249658, G9000347272, Training in Basic and Translational Digestive Sciences, Center for Health Innovation and Maximizing Elder Care, G918445665
OpenAlex ID: W2594772931